Community Health Services

Applied filters

Community Health Services

Care Setting (24)
- Adults (8)
- Care homes (8)
- Care of the elderly (1)
- Community Health Services (24)
- Health and Justice (15)
- Occupational Health (3)
- Palliative and End of Life Care (2)
- Primary Care (17)
- Transfer of care (10)
- Trusts (20)
Events (1)
- Past Events (1)
Guidance (20)
- Administering (8)
- Adverse effects (1)
- Implementation (1)
- Medication Safety (2)
- Patient Group Directions (11)
- Policy, Commissioning and Managerial (2)
- Preparing (1)
- Service advice and planning (2)
- Supply (9)
Medicine (2)
- Almotriptan (1)
- Amitriptyline (1)
- Bupropion (1)
- Buspirone (1)
- Carbamazepine (1)
- Chlorphenamine (1)
- Citalopram (1)
- Clomipramine (1)
- Dextromethorphan (1)
- Dosulepin (1)
- Doxepin (1)
- Duloxetine (1)
- Eletriptan (1)
- Ergotamine (1)
- Escitalopram (1)
- Fentanyl (1)
- Fluoxetine (1)
- Fluvoxamine (1)
- Frovatriptan (1)
- Granisetron (1)
- Imipramine (1)
- Influenza vaccine (1)
- Isocarboxazid (1)
- Levodopa (1)
- Linezolid (1)
- Lithium (1)
- Lofepramine (1)
- Methadone (1)
- Methylthioninium chloride (1)
- Metoclopramide (1)
- Mirtazapine (1)
- Moclobemide (1)
- Naratriptan (1)
- Nortriptyline (1)
- Ondansetron (1)
- Oxitriptan (1)
- Oxycodone (1)
- Paroxetine (1)
- Pentazocine (1)
- Pethidine (1)
- Phenelzine (1)
- Procarbazine (1)
- Rasagiline (1)
- Rizatriptan (1)
- Selegiline (1)
- Sertraline (1)
- St. John's wort (1)
- Sumatriptan (1)
- Tapentadol (1)
- Tramadol (1)
- Tranylcypromine (1)
- Trazodone (1)
- Trimipramine (1)
- Tryptophan (1)
- Venlafaxine (1)
- Zolmitriptan (1)
Medicines planning (4)
- Patient Group Direction Planning (4)
Publications (3)
- Research and audits (1)
- Summary advice (1)
- Templates (1)
Specialty (2)
- Mental health and illness (1)
- Vaccinating (1)
Training and Development (2)

What is serotonin syndrome and which medicines cause it?

22 May 2020This Medicines Q&A outlines the causes and symptoms of serotonin syndrome and provides examples of medicines with the potential to cause serotonin syndrome.

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Patient Group Direction use in Hospital at Home, including virtual ward, services

28 March 2023Considerations required before implementing Patient Group Direction (PGDs) in Hospital at Home, including virtual ward, services

Using medicines under PGD as part of a clinical trial or study

26 June 2019Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot

Outsourcing Hospital Pharmacy Outpatient Dispensing (OPD) Services - Challenges and Opportunities

22 October 2018“A study to compare the different models of outsourced OPD hospital pharmacy services and assess the potential strategic impact on other hospital pharmacy services and…

Semi-acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

SPS Virtual Wards Conference: Opportunities for Pharmacy

21 September 2022A short conference to support pharmacy services contributing to the development and delivery of virtual wards

Bank and agency staff and Patient Group Directions

25 February 2020The below summarises the advice on the use of PGDs by bank and agency staff working within organisations.

Understanding transcribing for medicines administration

22 February 2022Transcribing for medicines administration in healthcare requires assessment and mitigation against identified risks. These risks vary according to setting.

Non-acute settings with healthcare input and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

SPS - Specialist Pharmacy Service

NHS